Fapon and Stanford Healthcare Innovation Lab co-host virtual conference on RNA delivery and gene editing featuring nobel prize winner

On March 20, the groundbreaking virtual conference "In Vivo Frontiers: The Promise and Progress of RNA Delivery & Gene Editing," hosted by the Stanford Healthcare Innovation Lab in collaboration with Fapon, took place successfully. Distinguished speakers, including Nobel Prize Winner Jennifer Doudna and renowned scientist Robert Langer, alongside other leading experts, presented in the event.

The conference delved into the transformative potential of RNA delivery and gene editing, highlighting the latest advancements and future prospects in these rapidly evolving fields. Covering topics from the current state of CRISPR technology to innovative applications of molecular technologies and RNA therapies in the industry, the event provided attendees with valuable insights into the forefront of biotechnology.

Leveraging cutting-edge technologies and strategic partnerships, Fapon is dedicated to developing technologies to advance RNA-based therapeutics. Collaborating with leading experts such as Alexander Wesselhoeft, Fapon focuses on creating state-of-the-art platforms, including circRNA platform and a novel delivery system, to address the bottlenecks in circRNA field.

In addition to advancing circRNA technology, Fapon has established an innovative biopharma business focusing on tumors and autoimmune diseases while tapping into novel antibody drugs and fusion proteins. Moreover, Fapon places significant emphasis on Artificial Intelligence, developing innovative applications such as AI-enabled bio-molecule design and AI-driven multi-omics platforms to propel industry progress.

Looking ahead, Fapon will continue to address critical technological challenges as well as accelerate the development of diagnostics and therapeutics, ultimately shaping the future of the healthcare industry.